• 디자인융복합연구
• /
• 제15권4호
• /
• pp.17-29
• /
• 2016

편의점에서 판매되고 있는 안전상비의약품은 약사법에 따라 의약품의 용기나 포장 또는 첨부문서 기재사항을 정함으로써 의약품의 투약과실을 예방하고 알기 쉽고 정확한 의약품 정보를 제공하고 있다. 하지만 제한된 포장면적으로 인해 정보의 가독성이 떨어져 소비자들이 구매하기에는 어려움이 따른다. 본 연구에서 알약 형태인 8개 품목을 중심으로 규정에 따른 포장 분석을 실시하고 외국인 10명과 내국인 20명의 소비자들을 대상으로 설문 및 심층 인터뷰를 통하여 사용자 의식 조사를 진행하였다. 그 결과, 가장 많이 구매하는 품목은 해열제라는 것과 구매 전 의약품 포장에서 찾는 정보는 효능·효과, 용량·용법, 사용상의 주의사항의 순이라는 것을 알 수 있었다. 포장정보에 대한 이해도는 내국인의 경우 이해에 큰 문제가 없었던 반면, 포장의 모든 표기가 한글로만 되어있어 외국인의 40%이상에서 이해하지 못한다고 응답하였다. 디자인 개선안으로 픽토그램과 영어표기를 적용해 효능·효과와 용량·용법, 연령 총 세 가지로 각 포장의 윗면 오른쪽에 위치하여 한 눈에 어떤 약인지 구별할 수 있게 하자는 제안하고자 한다. 이를 통해 소비자들이 구매함에 있어 이해도와 편의성을 높일 수 있길 기대한다.

• 한국통계학회:학술대회논문집
• /
• 한국통계학회 2002년도 춘계 학술발표회 논문집
• /
• pp.67-72
• /
• 2002

A Bayesian testing procedure is proposed for assessment of bioequivalence in both mean and variance which ensures population bioequivalence under normality assumption. We derive the joint posterior distribution of the means and variances in a standard 2 ${\times}$ 2 crossover experimental design and propose a Bayesian testing procedure for bioequivalence based on a Markov chain Monte Carlo methods. The proposed method is applied to a real data set.

• 한국섬유공학회:학술대회논문집
• /
• 한국섬유공학회 2003년도 봄 학술발표회 논문집
• /
• pp.297-298
• /
• 2003

Chitin is a natural biopolymer that, with its derivative chitosan, has been represented as a biomaterial with considerable potential in wide ranging medical applications. But there are some limitations in using chitosan as attained, for instance, the problem of water solubility$^1$. In order to use chitosan in various applications (e.g. drug carrier), chemical modifications are often necessary$^2$. (omitted)

• Journal of the Korean Data and Information Science Society
• /
• 제18권3호
• /
• pp.645-657
• /
• 2007

Several statistical procedures for assessment of bioequivalence of variabilities between two drug formulations in bioequivalence trials are reviewed and modified methods for assessing total variability are suggested. The problem of the current US FDA aggregate criterion for population bioequivalence and the necessity of disaggregate criterion are discussed with an illustrated example.

• 대한약학회:학술대회논문집
• /
• 대한약학회 2001년도 Proceedings of International Convention of the Pharmaceutical Society of Korea
• /
• pp.244.3-245
• /
• 2001

• Journal of Pharmaceutical Investigation
• /
• 제35권3호
• /
• pp.165-171
• /
• 2005

Itraconazole is a triazole antifungal agent to inhibit most fungal pathogens. However, it is difficult for itraconazloe to be delivered by topical system due to its poor aqueous solubility. First, niosomes containing drug were prepared with span 60, cholesterol. tocopherol and poloxamer 407 as vesicle forming agents in an effort to increase solubility of itraconazole. And then prepared niosomes were dispersed in O/W creams (containing xanthan gum, glycerin, vaseline, glyceryl monostearate and $Cerix^{\circledR}-5$) or gels (containing xanthan gum and poloxamer 407). Both creams and gels were evaluated with respect to their rheological properties, in vitro permeation through excised skin of hairless mouse. Creams or gels containing niosome showed pseudoplastic flow and hysteresis loop. For both creams and gels, viscosity was increased with increasing the content of glycerine or vaseline and the content of gel forming polymer, respectively. In creams, the permeability of drug to skin was decreased with increasing the viscosity of cream. The permeability of drug was affected by pH as well as viscosity of gel. In vitro permeation test results demonstrated that cream formulations showed better permeability than gels. In conclusion, these results suggest that creams formulation containing niosome can be useful for the topical delivery of intraconazole.

• Journal of Microbiology and Biotechnology
• /
• 제27권5호
• /
• pp.878-895
• /
• 2017

Phosphorylation, a critical mechanism in biological systems, is estimated to be indispensable for about 30% of key biological activities, such as cell cycle progression, migration, and division. It is synergistically balanced by kinases and phosphatases, and any deviation from this balance leads to disease conditions. Pathway or biological activity-based abnormalities in phosphorylation and the type of involved phosphatase influence the outcome, and cause diverse diseases ranging from diabetes, rheumatoid arthritis, and numerous cancers. Protein tyrosine phosphatases (PTPs) are of prime importance in the process of dephosphorylation and catalyze several biological functions. Abnormal PTP activities are reported to result in several human diseases. Consequently, there is an increased demand for potential PTP inhibitory small molecules. Several strategies in structure-based drug designing techniques for potential inhibitory small molecules of PTPs have been explored along with traditional drug designing methods in order to overcome the hurdles in PTP inhibitor discovery. In this review, we discuss druggable PTPs and structure-based virtual screening efforts for successful PTP inhibitor design.

• Journal of Pharmaceutical Investigation
• /
• 제36권4호
• /
• pp.263-269
• /
• 2006

Deficiencies in the early ADMET(absorption, distribution, metabolism, elimination and toxicity) information on drug candidate extract a significant economic penalty on pharmaceutical firms. Microscale cell culture analogue-microscale gastrointestinal(${\mu}CCA-{\mu}GI$) device using Caco 2, L2 and HEp G2/C3A cells, which mimic metabolic process after absorption occurring in humans was used to investigate the toxicity of the model chemical, acetaminophen(AAP). The toxicity of acetaminophen determined after induction of CYP 1A1/2 in Caco 2 cells was not significant. In a coculture system, although no significant reduction in viability of HEp G2/C3A and L2 cells was found, approximately 5 fold increase in the CYP 1A1/2 activity was observed. These results appear to be related to organ-organ interaction. The oral administration of a drug requires addition of the absorption process through small intestine to the current ${\mu}CCA$ device. Therefore, a perfusion coculture system was employed for the evaluation of the absolution across the small intestine and resulting toxicity in the liver and lung. This system give comprehensive and physiologic information on oral uptake and resulting toxicity as in the body. The current ${\mu}CCA$ device can be used to demonstrate the toxic effect due to organ to organ interaction after oral administration,

• Biotechnology and Bioprocess Engineering:BBE
• /
• 제9권3호
• /
• pp.191-195
• /
• 2004

Drug delivery systems that are based on pectin have been studied for colon specific delivery using the specific activity of colon microflora. The aim of this study was to design a novel method of manufacturing pectin microspheres without oils and surfactants and to investigate the potential use of the pectin microspheres as an oral colon-specific drug carrier. The pectin microspheres were successfully formed using the spray drying method and crosslinking with calcium chloride. From the crosslinked pectin microspheres, indomethacin (IND) release was more suppressed than its release from non-crosslinked microspheres. In a low pH (pH 1.4) environment, the pectin microspheres released IND at an amount of about 18${\pm}$2% of the total loaded weight for 24 h while the release rate of IND was stimulated at neutral pH (pH 7.4). IND release from the pectin microspheres was increased by the addition of pectinase. The results clearly demonstrate that the pectin microspheres that were prepared by the spray drying and crosslinking methods are potential carriers for colon-specific drug deliveries.

• 전기전자학회논문지
• /
• 제21권3호
• /
• pp.320-330
• /
• 2017

Porous nanosilica (PNS) has been identified as a potential candidate for controlled drug delivery. However, unmodified PNS-based carriers exhibited an initial release of loaded bioactive agents, which may limit their potential clinical applications. In this study, the surface of PNS was functionalized with adamantylamine (ADA) via disulfide bonds (-S-S-), PNS-S-S-ADA, which was then modified with cyclodextrin (CD)-heparin (Hep) (CD-Hep), PNS-S-S-CDH, for redox triggered rhodamine B (RhB) delivery. The obtained samples were then characterized by proton nuclear magnetic resonance ($^{1}H\;NMR$), Fourier transform infrared (FTIR), and transmission electron microscope (TEM). These results showed that PNS-S-S-CDH was successfully formed with spherical shape and average diameter of $45.64{\pm}2.33nm$. In addition, RhB was relatively encapsulated in the PNS-S-S-CDH (RhB@PNS-S-S-CDH) and slowly released up to 3 days. The release of RhB, in particular, was triggered due to the cleavage of -S-S- in the presence of dithiothreitol (DTT). It might be anticipated that the modified PNS can be used as redox-responsive drug delivery system in cancer therapy.